Gabrielle DeGravina | CG Capital |
David Dodd | Chairman, President and Chief Executive Officer |
Mark Reynolds | Chief Financial Officer |
Mark Newman | Chief Scientific Officer |
John Sharkey | Head, Business Development |
Kelly McKee | Chief Medical Officer |
Jeffrey Kraws | Crystal Research Associates |
Robert LeBoyer | Noble Capital |
Good afternoon and welcome everyone to the GeoVax Third Quarter 2022 Corporate Update Call. My name is Ralph and I will facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, PhD, Chief Scientific Officer; Kelly McKee, M.D., M.P.H, Chief Medical Officer; and John Sharkey, PhD, Vice President, Business Development. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.